Wave Life Sciences Ltd. (WVE)
NASDAQ: WVE · Real-Time Price · USD
7.52
+0.58 (8.36%)
At close: Apr 28, 2026, 4:00 PM EDT
7.52
0.00 (0.00%)
After-hours: Apr 28, 2026, 4:25 PM EDT
Wave Life Sciences Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Revenue | 71.8 | 42.73 | 108.3 | 113.31 | 3.65 | 40.96 | |
| Revenue Growth (YoY) | -31.58% | -60.55% | -4.42% | 3005.10% | -91.09% | 104.03% | |
| Cost of Revenue | 182.78 | 182.78 | 159.68 | 130.01 | 115.86 | 121.88 | |
| Gross Profit | -110.98 | -140.05 | -51.38 | -16.7 | -112.21 | -80.91 | |
| Selling, General & Admin | 79.08 | 75.33 | 59.02 | 51.29 | 50.51 | 46.11 | |
| Operating Expenses | 85.9 | 75.33 | 59.02 | 51.29 | 50.51 | 46.11 | |
| Operating Income | -196.88 | -215.38 | -110.4 | -68 | -162.72 | -127.02 | |
| Interest & Investment Income | 12.89 | 10.48 | 10.16 | 7.93 | 1.57 | 0.03 | |
| Other Non Operating Income (Expenses) | 0.4 | 0.53 | 3.23 | 1.88 | 0.01 | 4.54 | |
| Pretax Income | -183.59 | -204.38 | -97.01 | -58.19 | -161.14 | -122.45 | |
| Income Tax Expense | - | - | - | -0.68 | 0.68 | -0.2 | |
| Net Income | -183.59 | -204.38 | -97.01 | -57.51 | -161.82 | -122.25 | |
| Net Income to Common | -183.59 | -204.38 | -97.01 | -57.51 | -161.82 | -122.25 | |
| Shares Outstanding (Basic) | 178 | 169 | 138 | 106 | 79 | 52 | |
| Shares Outstanding (Diluted) | 178 | 169 | 138 | 106 | 79 | 52 | |
| Shares Change (YoY) | 21.45% | 21.96% | 30.33% | 34.55% | 52.16% | 32.12% | |
| EPS (Basic) | -1.03 | -1.21 | -0.70 | -0.54 | -2.05 | -2.36 | |
| EPS (Diluted) | -1.03 | -1.21 | -0.70 | -0.54 | -2.05 | -2.36 | |
| Free Cash Flow | -185 | -188.21 | -151.96 | -20.55 | -129.14 | -89.55 | |
| Free Cash Flow Per Share | -1.04 | -1.12 | -1.10 | -0.19 | -1.64 | -1.73 | |
| Gross Margin | -154.57% | - | -47.44% | -14.74% | - | -197.52% | |
| Operating Margin | -274.21% | -504.09% | -101.94% | -60.01% | -4459.30% | -310.07% | |
| Profit Margin | -255.70% | -478.34% | -89.57% | -50.76% | -4434.72% | -298.42% | |
| Free Cash Flow Margin | -257.66% | -440.50% | -140.31% | -18.13% | -3539.11% | -218.61% | |
| EBITDA | -193.47 | -211.94 | -106.51 | -63 | -156.15 | -119.53 | |
| EBITDA Margin | -269.47% | - | -98.34% | -55.60% | - | -291.80% | |
| D&A For EBITDA | 3.41 | 3.44 | 3.9 | 5 | 6.57 | 7.48 | |
| EBIT | -196.88 | -215.38 | -110.4 | -68 | -162.72 | -127.02 | |
| EBIT Margin | -274.21% | - | -101.94% | -60.01% | - | - | |
Source: S&P Capital IQ. Standard template.
Financial Sources.